See more : Holdco Nuvo Group D.G Ltd. Warrants (NUVOW) Income Statement Analysis – Financial Results
Complete financial analysis of Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Shijiazhuang Yiling Pharmaceutical Co., Ltd., a leading company in the Biotechnology industry within the Healthcare sector.
- Unicharm Corporation (UNCHF) Income Statement Analysis – Financial Results
- SSY Group Limited (LJUIF) Income Statement Analysis – Financial Results
- Jupiter Infomedia Limited (JUPITERIN.BO) Income Statement Analysis – Financial Results
- Trakm8 Holdings PLC (TRAK.L) Income Statement Analysis – Financial Results
- BZAM Ltd. (Z6A.F) Income Statement Analysis – Financial Results
Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ)
About Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of medicine primarily in China. The company operates through Chemical and Biological Medicine, and Health Industry segments. It offers drugs for cardiac and premature ventricular beats, sinus bradycardia, chronic heart failure, integrated rhythm regulation, cold and respiratory, cardiovascular and cerebrovascular diseases, diabetes field, tumor medication, and others. The company sells its products through physical display and online. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is based in Shijiazhuang, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10.32B | 12.53B | 10.12B | 8.78B | 5.83B | 4.81B | 4.08B | 3.82B | 3.18B | 2.92B | 2.49B | 1.65B | 1.95B | 1.65B | 1.63B | 938.56M |
| Cost of Revenue | 4.41B | 4.54B | 3.68B | 3.12B | 2.11B | 1.63B | 1.30B | 1.29B | 1.16B | 1.08B | 830.50M | 524.04M | 617.69M | 554.70M | 636.81M | 379.73M |
| Gross Profit | 5.91B | 7.99B | 6.44B | 5.66B | 3.72B | 3.18B | 2.78B | 2.53B | 2.02B | 1.84B | 1.66B | 1.12B | 1.34B | 1.09B | 995.52M | 558.82M |
| Gross Profit Ratio | 57.28% | 63.77% | 63.62% | 64.49% | 63.84% | 66.13% | 68.05% | 66.29% | 63.44% | 63.11% | 66.65% | 68.21% | 68.38% | 66.37% | 60.99% | 59.54% |
| Research & Development | 853.19M | 1.03B | 792.16M | 654.39M | 390.75M | 316.71M | 217.44M | 187.72M | 154.63M | 139.75M | 139.38M | 111.05M | 82.17M | 0.00 | 0.00 | 0.00 |
| General & Administrative | 185.71M | 158.24M | 165.91M | 166.59M | 114.60M | 83.05M | 59.96M | 56.65M | 101.80M | 72.00M | 66.51M | 58.45M | 34.22M | 153.59M | 101.91M | 76.82M |
| Selling & Marketing | 1.69B | 3.26B | 3.43B | 3.04B | 2.23B | 1.82B | 1.60B | 1.43B | 1.16B | 1.14B | 1.13B | 737.32M | 638.01M | 571.39M | 528.44M | 315.20M |
| SG&A | 3.17B | 3.42B | 3.60B | 3.20B | 2.34B | 1.90B | 1.66B | 1.49B | 1.26B | 1.21B | 1.20B | 795.77M | 672.23M | 724.98M | 630.35M | 392.02M |
| Other Expenses | 144.44M | 576.87M | 366.58M | 322.97M | 301.58M | -17.95M | -10.90M | 14.32M | 725.46K | 3.85M | 16.14M | 28.15M | 42.92M | 23.77M | 15.67M | -5.96M |
| Operating Expenses | 4.13B | 5.03B | 4.76B | 4.18B | 3.03B | 2.50B | 2.14B | 1.90B | 1.54B | 1.46B | 1.42B | 975.48M | 846.67M | 747.46M | 650.55M | 404.61M |
| Cost & Expenses | 8.54B | 9.57B | 8.44B | 7.30B | 5.14B | 4.13B | 3.45B | 3.19B | 2.71B | 2.54B | 2.26B | 1.50B | 1.46B | 1.30B | 1.29B | 784.34M |
| Interest Income | 12.75M | 12.90M | 20.45M | 7.02M | 2.28M | 17.70M | 4.66M | 0.00 | 2.80M | 8.61M | 34.25M | 50.58M | 26.60M | 1.84M | 1.06M | 487.26K |
| Interest Expense | 38.90M | 33.80M | 33.97M | 3.85M | 71.90K | 1.00M | 1.53M | 5.09M | 2.77M | 2.79M | 226.56K | 6.88M | 20.20M | 7.91M | 2.02M | 1.74M |
| Depreciation & Amortization | 547.41M | 452.13M | 366.98M | 274.94M | 263.70M | 257.53M | 247.48M | 234.08M | 144.56M | 85.54M | 64.03M | 61.19M | 58.68M | 48.98M | 34.05M | 29.73M |
| EBITDA | 2.29B | 3.28B | 1.96B | 1.71B | 978.16M | 960.91M | 896.72M | 870.87M | 646.72M | 466.73M | 353.37M | 285.92M | 597.89M | 420.84M | 388.45M | 175.71M |
| EBITDA Ratio | 22.16% | 26.93% | 19.94% | 20.13% | 16.68% | 19.91% | 21.71% | 22.44% | 19.84% | 15.96% | 14.32% | 17.52% | 31.58% | 25.56% | 24.24% | 19.01% |
| Operating Income | 1.78B | 2.83B | 1.57B | 1.44B | 710.18M | 718.95M | 649.24M | 623.69M | 499.03M | 409.99M | 273.23M | 188.22M | 489.59M | 345.72M | 339.64M | 150.37M |
| Operating Income Ratio | 17.25% | 22.58% | 15.51% | 16.37% | 12.19% | 14.93% | 15.91% | 16.33% | 15.67% | 14.04% | 10.97% | 11.42% | 25.07% | 20.96% | 20.81% | 16.02% |
| Total Other Income/Expenses | -95.62M | -48.91M | -15.35M | -15.56M | -2.29M | -17.95M | -10.86M | 3.36M | 358.21K | 566.17K | 16.11M | 28.01M | 42.92M | 23.04M | 14.67M | -6.14M |
| Income Before Tax | 1.68B | 2.78B | 1.55B | 1.42B | 707.89M | 701.00M | 638.35M | 637.69M | 499.39M | 410.56M | 289.34M | 216.24M | 532.50M | 368.76M | 354.31M | 144.23M |
| Income Before Tax Ratio | 16.32% | 22.19% | 15.36% | 16.20% | 12.15% | 14.56% | 15.64% | 16.69% | 15.68% | 14.05% | 11.62% | 13.12% | 27.26% | 22.36% | 21.71% | 15.37% |
| Income Tax Expense | 339.91M | 423.82M | 212.09M | 207.54M | 104.84M | 108.05M | 101.56M | 101.76M | 72.58M | 56.06M | 45.05M | 30.43M | 78.43M | 53.74M | 56.80M | 21.98M |
| Net Income | 1.35B | 2.36B | 1.34B | 1.22B | 606.50M | 599.22M | 540.71M | 542.02M | 430.49M | 354.50M | 244.29M | 185.81M | 454.07M | 315.56M | 297.18M | 122.12M |
| Net Income Ratio | 13.11% | 18.85% | 13.28% | 13.88% | 10.41% | 12.45% | 13.25% | 14.19% | 13.52% | 12.14% | 9.81% | 11.27% | 23.25% | 19.13% | 18.21% | 13.01% |
| EPS | 0.81 | 1.41 | 0.80 | 0.73 | 0.36 | 0.36 | 0.32 | 0.34 | 0.28 | 0.23 | 0.16 | 0.12 | 0.32 | 0.26 | 0.25 | 0.10 |
| EPS Diluted | 0.81 | 1.41 | 0.80 | 0.73 | 0.36 | 0.36 | 0.32 | 0.34 | 0.27 | 0.23 | 0.16 | 0.12 | 0.32 | 0.26 | 0.25 | 0.10 |
| Weighted Avg Shares Out | 1.67B | 1.67B | 1.67B | 1.67B | 1.67B | 1.68B | 1.68B | 1.55B | 1.55B | 1.55B | 1.55B | 1.53B | 1.41B | 1.22B | 1.20B | 1.20B |
| Weighted Avg Shares Out (Dil) | 1.67B | 1.67B | 1.67B | 1.67B | 1.67B | 1.68B | 1.68B | 1.59B | 1.59B | 1.55B | 1.55B | 1.53B | 1.41B | 1.22B | 1.20B | 1.20B |
Source: https://incomestatements.info
Category: Stock Reports